Literature DB >> 27193450

Cancer Stem Cells: Basic Concepts and Therapeutic Implications.

Dany Nassar1, Cédric Blanpain1,2.   

Abstract

Different mechanisms contribute to intratumor heterogeneity, including genetic mutations, the microenvironment, and the existence of subpopulations of cancer cells with increased renewal capacity and the ability to recapitulate the heterogeneity found in primary tumors, which are referred to as cancer stem cells (CSCs). In this review, we discuss how the concept of CSCs has been defined, what assays are currently used to define the functional properties of CSCs, what intrinsic and extrinsic mechanisms regulate CSC functions, how plastic CSCs are, and the importance of epithelial-to-mesenchymal transition in conferring CSC properties. Finally, we discuss the mechanisms by which CSCs may resist medical therapy and contribute to tumor relapse.

Entities:  

Keywords:  cancer; cancer stem cells; epithelial-to-mesenchymal transition; resistance to therapy; tumor heterogeneity; tumor microenvironment

Mesh:

Substances:

Year:  2016        PMID: 27193450     DOI: 10.1146/annurev-pathol-012615-044438

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  206 in total

1.  MiR-146a promotes the asymmetric division and inhibits the self-renewal ability of breast cancer stem-like cells via indirect upregulation of Let-7.

Authors:  Rui Liang; Yuan Li; Meng Wang; Shou-Ching Tang; Guodong Xiao; Xin Sun; Gang Li; Ning Du; Dapeng Liu; Hong Ren
Journal:  Cell Cycle       Date:  2018-07-14       Impact factor: 4.534

Review 2.  Physics of growing biological tissues: the complex cross-talk between cell activity, growth and resistance.

Authors:  Martine Ben Amar; Pierre Nassoy; Loic LeGoff
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2019-05-06       Impact factor: 4.226

3.  Chemotherapeutic tumor microparticles combining low-dose irradiation reprogram tumor-promoting macrophages through a tumor-repopulating cell-curtailing pathway.

Authors:  Yanling Sun; Zu'an Zheng; Huafeng Zhang; Yuandong Yu; Jingwei Ma; Ke Tang; Pingwei Xu; Tiantian Ji; Xiaoyu Liang; Degao Chen; Xun Jin; Tianzhen Zhang; Zhixiong Long; Yuying Liu; Bo Huang
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

Review 4.  Lung cancer and β-glucans: review of potential therapeutic applications.

Authors:  Raheleh Roudi; Shahla Roudbar Mohammadi; Maryam Roudbary; Monireh Mohsenzadegan
Journal:  Invest New Drugs       Date:  2017-03-16       Impact factor: 3.850

5.  Synergistic anti-cancer effects of epigenetic drugs on medulloblastoma cells.

Authors:  Juan Yuan; Núria Llamas Luceño; Bjoern Sander; Monika M Golas
Journal:  Cell Oncol (Dordr)       Date:  2017-04-20       Impact factor: 6.730

6.  CD133 Expression Predicts Relapse in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemotherapy.

Authors:  Haruka Oi; Takashi Okuyama; Shunya Miyazaki; Yuko Ono; Masatoshi Oya
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

7.  Activation of D2 Dopamine Receptors in CD133+ve Cancer Stem Cells in Non-small Cell Lung Carcinoma Inhibits Proliferation, Clonogenic Ability, and Invasiveness of These Cells.

Authors:  Soumyabrata Roy; Kai Lu; Mukti Kant Nayak; Avishek Bhuniya; Tithi Ghosh; Suman Kundu; Sarbari Ghosh; Rathindranath Baral; Partha Sarathi Dasgupta; Sujit Basu
Journal:  J Biol Chem       Date:  2016-12-05       Impact factor: 5.157

8.  Coopted temporal patterning governs cellular hierarchy, heterogeneity and metabolism in Drosophila neuroblast tumors.

Authors:  Raphaël Clément; Cassandra Gaultier; Sara Genovese; Florence Besse; Karine Narbonne-Reveau; Fabrice Daian; Sophie Foppolo; Nuno Miguel Luis; Cédric Maurange
Journal:  Elife       Date:  2019-09-30       Impact factor: 8.140

9.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

10.  Single-Cell RNA Sequencing of Ovarian Cancer: Promises and Challenges.

Authors:  Shobhana Talukdar; Zenas Chang; Boris Winterhoff; Timothy K Starr
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.